Showing results (141-150 of 162) with videos related to
Sort By:
Pageof 17
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 9, 2020
Lipid-lowering nutraceuticals update on scientific evidenceGiuseppe Derosa, Alessandro Colletti, Pamela Maffioli, et al.Metabolism: Clinical and Experimental|April 29, 2010
Effects of combination of sibutramine and L-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patientsGiuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, et al.Drug Design, Development and Therapy|August 24, 2017
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patientsLuigina Guasti, Giovanni Gaudio, Alessandro Lupi, et al.Cardiovascular Therapeutics|November 19, 2016
Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trialGiuseppe Derosa, Pamela Maffioli, Maria D'Avino, et al.Journal of Diabetes and Its Complications|June 30, 2023
ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON)Giuseppe Derosa, Manfredi Rizzo, Natale Daniele Brunetti, et al.Internal Medicine (Tokyo, Japan)|March 3, 2009
Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramineGiuseppe Derosa, Roberto Mereu, Sibilla A T Salvadeo, et al.Frontiers in Nutrition|June 10, 2022
Probiotic Therapy With VSL#3® in Patients With NAFLD: A Randomized Clinical TrialGiuseppe Derosa, Luigina Guasti, Angela D'Angelo, et al.Microvascular Research|January 19, 2010
Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjectsGiuseppe Derosa, Angela D'Angelo, Sibilla A T Salvadeo, et al.Endocrine Journal|April 9, 2009
Effects of insulin therapy with continuous subcutaneous insulin infusion (CSII) in diabetic patients: comparison with multi-daily insulin injections therapy (MDI)Giuseppe Derosa, Pamela Maffioli, Angela D'Angelo, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 13, 2009
Modulation of adipokines and vascular remodelling markers during OGTT with acarbose or pioglitazone treatmentGiuseppe Derosa, Angela D'Angelo, Sibilla A T Salvadeo, et al.Pageof 17